Competitive Technologies, Inc. Licenses Homocysteine Assay To Genzyme Corporation

FAIRFIELD, Conn.--(BUSINESS WIRE)--Dec. 21, 2005--Competitive Technologies, Inc. (AMEX: CTT) today announced that a homocysteine assay license has been granted to Genzyme Diagnostics under CTT’s U.S. Patent Number 4,940,658 relating to homocysteine medical tests. The license includes an initial license fee and payments, releasing Equal Diagnostics (a Genzyme business) customers of any obligation to pay royalties to CTT for homocysteine test results obtained using Genzyme’s Equal Diagnostics assays in the past. The license also includes royalties on future product sales.

MORE ON THIS TOPIC